Search Results 871-880 of 17132 for treatment resistant depression

  1. Hormone Therapy For Breast Cancer Clinical Trials - Mayo Clinic Research

    This phase II trial studies how well alisertib with or without fulvestrant works in treating patients with endocrine-resistant breast cancer that has spread to ...

  2. Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants with Relapsed or Refractory Multiple Myeloma · Share · Facebook · Twitter.

  3. Heart Rhythm Disease Program - Cardiovascular Research Center - Mayo Clinic Research

    Mayo Clinic led the Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) trial. ... treatment of refractory ventricular ...

  4. Dorsal spinal cord stimulation vs medical management for the treatment of low back pain - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Study assesses opioid usage patterns in patients with lupus - Mayo Clinic News Network

    As a result, different pain management strategies, including opioid therapy, may be needed. ... It also found that patients with mood disorders like depression ...

  6. About CAR-T cell therapy - Mayo Clinic

    Aggressive B-cell lymphoma not otherwise specified (NOS); Mantle cell lymphoma; Follicular lymphoma; Multiple myeloma. People who have relapsed or refractory ...

  7. Acoustic Resonance Therapy (ART) to Cognitive Behavioral Therapy for Insomnia (CBT-I) for Treating Patients with Moderate to Severe Chronic Insomnia - Mayo Clinic

    Participants with severe mental disorders, such as schizophrenia, severe major depression, severe anxiety, bipolar disorder, dementia, substance use ...

  8. Oncology (Medical) - Clinical trials - Mayo Clinic

    A Study to Evaluate Abemaciclib for Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer ... Study of Tumor-treating Fields to Treat ...

  9. A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) - Mayo Clinic

    A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) · Share · Facebook ...

  10. Find clinical trials - Oncology (Medical)

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...